The blood-brain barrier in health and chronic neurodegenerative disorders BV Zlokovic Neuron 57 (2), 178-201, 2008 | 3854 | 2008 |
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders BV Zlokovic Nature Reviews Neuroscience 12 (12), 723-738, 2011 | 3106 | 2011 |
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders MD Sweeney, AP Sagare, BV Zlokovic Nature Reviews Neurology 14 (3), 133-150, 2018 | 2541 | 2018 |
Blood-brain barrier breakdown in the aging human hippocampus A Montagne, SR Barnes, MD Sweeney, MR Halliday, AP Sagare, Z Zhao, ... Neuron 85 (2), 296-302, 2015 | 2021 | 2015 |
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain R Deane, S Du Yan, RK Submamaryan, B LaRue, S Jovanovic, E Hogg, ... Nature medicine 9 (7), 907-913, 2003 | 1792 | 2003 |
Clearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrier M Shibata, S Yamada, SR Kumar, M Calero, J Bading, B Frangione, ... The Journal of clinical investigation 106 (12), 1489-1499, 2000 | 1777 | 2000 |
Blood-brain barrier: from physiology to disease and back MD Sweeney, Z Zhao, A Montagne, AR Nelson, BV Zlokovic Physiological reviews, 2018 | 1769 | 2018 |
Clearance systems in the brain—implications for Alzheimer disease JM Tarasoff-Conway, RO Carare, RS Osorio, L Glodzik, T Butler, ... Nature reviews neurology 11 (8), 457-470, 2015 | 1604 | 2015 |
Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging RD Bell, EA Winkler, AP Sagare, I Singh, B LaRue, R Deane, BV Zlokovic Neuron 68 (3), 409-427, 2010 | 1595 | 2010 |
Establishment and dysfunction of the blood-brain barrier Z Zhao, AR Nelson, C Betsholtz, BV Zlokovic Cell 163 (5), 1064-1078, 2015 | 1535 | 2015 |
Apolipoprotein E controls cerebrovascular integrity via cyclophilin A RD Bell, EA Winkler, I Singh, AP Sagare, R Deane, Z Wu, DM Holtzman, ... Nature 485 (7399), 512-516, 2012 | 1361 | 2012 |
Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction DA Nation, MD Sweeney, A Montagne, AP Sagare, LM D’Orazio, ... Nature medicine 25 (2), 270-276, 2019 | 1338 | 2019 |
Neurovascular mechanisms of Alzheimer's neurodegeneration BV Zlokovic Trends in neurosciences 28 (4), 202-208, 2005 | 1226 | 2005 |
Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease K Kisler, AR Nelson, A Montagne, BV Zlokovic Nature Reviews Neuroscience 18 (7), 419-434, 2017 | 1152 | 2017 |
Central nervous system pericytes in health and disease EA Winkler, RD Bell, BV Zlokovic Nature neuroscience 14 (11), 1398-1405, 2011 | 1127 | 2011 |
Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease RD Bell, BV Zlokovic Acta neuropathologica 118, 103-113, 2009 | 1099 | 2009 |
Pericytes of the neurovascular unit: key functions and signaling pathways MD Sweeney, S Ayyadurai, BV Zlokovic Nature neuroscience 19 (6), 771-783, 2016 | 1075 | 2016 |
LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms R Deane, Z Wu, A Sagare, J Davis, S Du Yan, K Hamm, F Xu, M Parisi, ... Neuron 43 (3), 333-344, 2004 | 1023 | 2004 |
APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline A Montagne, DA Nation, AP Sagare, G Barisano, MD Sweeney, ... Nature 581 (7806), 71-76, 2020 | 1006 | 2020 |
The cytoprotective protein C pathway LO Mosnier, BV Zlokovic, JH Griffin Blood 109 (8), 3161-3172, 2007 | 973 | 2007 |